MTMR3 and Fibroadenoma: The ROC curve was created to examine MTMR3’s and HULC’s diagnostic abilities, HULC was a statistically significant discriminator of all 4 groups: non-metastatic from metastatic (cutoff ≤ 2.356), non-metastatic from fibroadenoma (cutoff ≤ 2.357), non-metastatic from control (cutoff > 1.0), metastatic from fibroadenoma (cutoff > 2.88), metastatic from control (cutoff > 1.0), and fibroadenoma from control (cutoff > 1.0).